|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/19 | |
| A61K 31/445 | |||
| A61P 25/28 | |||
| A61K 31/196 | |||
| A61K 45/06 |
| (11) | Patento numeris | 2773337 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12778762.0 |
| Europos patento paraiškos padavimo data | 2012-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-09-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/071631 |
| Data | 2012-10-31 |
| (87) | Numeris | WO 2013/064579 |
| Data | 2013-05-10 |
| (30) | Numeris | Data | Šalis |
| 11306407 | 2011-10-31 | EP |
| (72) |
MOUTHON, Franck, FR
CHARVERIAT, Mathieu, FR
|
| (73) |
Commissariat ą l`Énergie Atomique et aux Énergies Alternatives,
Bātiment le Ponant D 25 rue Leblanc, 75015 Paris,
FR
|
| (54) | USE OF ANTI-CONNEXIN AGENTS FOR ENHANCING THE THERAPEUTIC EFFECT OF ACETYLCHOLINESTERASE INHIBITORS |
| USE OF ANTI-CONNEXIN AGENTS FOR ENHANCING THE THERAPEUTIC EFFECT OF ACETYLCHOLINESTERASE INHIBITORS |